Shopping Cart
- Remove All
- Your shopping cart is currently empty
Derazantinib Racemate (ARQ-087 Racemate) is the racemate of Derazantinib, an orally bioavailable, ATP-competitive tyrosine kinase inhibitor with potent activity against FGFR1/FGFR2/FGFR3 chondrocytes (IC50s: 4.5 nM/1.8 nM/4.5 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,681 | 6-8 weeks | |
50 mg | $2,519 | 6-8 weeks |
Description | Derazantinib Racemate (ARQ-087 Racemate) is the racemate of Derazantinib, an orally bioavailable, ATP-competitive tyrosine kinase inhibitor with potent activity against FGFR1/FGFR2/FGFR3 chondrocytes (IC50s: 4.5 nM/1.8 nM/4.5 nM). |
Alias | ARQ-087 Racemate |
Molecular Weight | 468.57 |
Formula | C29H29FN4O |
Cas No. | 2309668-44-6 |
Relative Density. | 1.218 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.